Akela Pharma Inc. Reports Results for the First Quarter of Fiscal 2008
MONTREAL, May 15 /CNW Telbec/ - Akela Pharma Inc. (TSX: AKL), a drug
development company focused on developing therapies for the inhalation and
pain markets, today announced its financial results for the three month period
ended March 31, 2008.